Classifications

• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07D—HETEROCYCLIC COMPOUNDS
  • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
  • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
  • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
  • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
  • C07D239/32—One oxygen, sulfur or nitrogen atom
  • C07D239/42—One nitrogen atom

Definitions

• the invention relates to 2-substituted pyrimidines of the formula I,
• n is an integer from 1 to 5;
• R 2 may additionally be hydrogen
• R b is hydrogen, CC 6 alkyl, C 2 -C 6 alkynyl;
• R c is hydrogen, methyl or dC cyl
• R w is halogen, OR x, NHR x, CC 6 alkyl, CC 4 alkoxycarbonyl, dC 4 - acylamino, [1,3] dioxolane-C ⁇ -C4 alkyl, [1.SjDioxane-C T C ⁇ alkyl, in which
• R x is hydrogen, methyl, allyl or propargyl.
• the invention relates to a process for the preparation of these compounds, agents containing them and their use for controlling phytopathogenic harmful fungi.
• WO-A 01/96314 discloses fungicidal pyrimidines which carry a cyanamino substituent in the 2-position. Furthermore, WO-A 03/43993 discloses fungicidal pyrimidines which, inter alia, carry an amide radical in the 2-position.
• the compounds I can be obtained in various ways. For example, it can be assumed that the sulfones of the formula II, the preparation of which is described in detail in WO-A 02/074753 or DE 10156279.9 and R 'is an optionally subst. CC 6 -alkyrest or an optionally subst. Phenylrest stands.
• metal cyanides III Metal cyanides are primarily alkali metal or alkaline earth metal cyanides or else covalent cyanides such as tin tetracyanide.
• the nitrile compound IV can be thiolysed with hydrogen sulfide under preferably acidic conditions to thioamide IA.
• the thiolysis takes place under the conditions of the Pinner reaction (see Preparation Examples).
• the alkylation with R b -X, wherein R b has the meaning mentioned above and X is a leaving group such as halide, sulfate or sulfonate, provides compounds of the type IB.
• the hydroxamic acid derivative V is obtained with CrC 6 -alkoxyamine under acidic conditions.
• the conversion into the thione compound ID can be carried out, for example, with phosphorus pentasulfide or Lawesson's reagent.
• R b -X where R b has the abovementioned meaning and X is a leaving group such as halide, sulfonate or sulfate, the compounds of the invention IC can be obtained.
• the residue R 3 (especially alkyl) in the 6-position on the pyrimidine ring can be introduced by reaction with transition metal catalysis, such as Ni or Pd catalysis. In some cases, it may be advisable to reverse the order and introduce the substituent R 3 before the substituent NR 1 R 2 .
• yw X w M y M is a metal ion of valency Y, such as B, Zn, Mg, Cu or Sn, X is chlorine, bromine, iodine or hydroxy, R 3 is preferably CC - Alkyl and w is a number from 0 to 3.
• This reaction can be carried out, for example, by the following methods: J. Chem. Soc. Perkin Trans. 1, 1187 (1994), ibid. 1, 2345 (1996); WO-A 99/41255; Aust. J. Chem., Vol. 43, 733 (1990); J. Org. Chem., Vol. 43, 358 (1978); J. Chem. Soc. Chem. Commun.
• R a is alkyl, alkenyl, alkynyl or cycloalkyl, for example, can also be prepared by the following synthetic routes.
• Scheme 6 shows an alternative synthetic route to the compounds IC according to the invention.
• the amides of the formula X are obtained in a modified Ritter reaction by means of alcohols of the formula R a -OH and trifluoroacetic anhydride (see Tetrahedron Lett, 1989, Vol 30, pages 581-82).
• Sulfurization with Lawesson reagent may be carried out according to the method described in J. Labeled Compd. Rad., 1988, Vol. 25, pp. 335-343.
• the alkylation with R 5 -X finally takes place according to methods customary in the literature, as described, for example, in Heterocycles, 1985, Vol 23, pages 2213-15.
• R 3 represents an alkyl group. If R 3 is a cyano group or an alkoxy substituent, the radical R 3 can be introduced by reaction with alkali metal cyanides or alkali metal alcoholates.
• Halogen fluorine, chlorine, bromine and iodine
• Alkyl saturated, straight-chain or branched hydrocarbon radicals having 1 to 4, 6 or 8 carbon atoms, for example d-Ce-alkyl such as methyl, ethyl, propyl, 1-methylethyl, butyl, 1-methyl-propyl, 2-methylpropyl, 1, 1 -Dimethylethyl, pentyl, 1-methylbutyl, 2-methylbutyl, 3-methylbutyl, 2,2-dimethylpropyl, 1-ethylpropyl, hexyl, 1, 1-dimethylpropyl, 1, 2-dimethylpropyl, 1-methylpentyl, 2-methylpentyl , 3-methylpentyl, 4-methylpentyl, 1, 1-dimethylbutyl, 1, 2-dimethylbutyl, 1, 3-dimethylbutyl, 2,2-dimethylbutyl, 2,3-dimethylbutyl, 3,3-dimethyl
• Haloalkyl straight-chain or branched alkyl groups having 1 to 6 carbon atoms (as mentioned above), wherein in these groups partially or completely the hydrogen atoms may be replaced by halogen atoms as mentioned above, eg CrC 2 -haloalkyl such as chloromethyl, bromomethyl, dichloromethyl, trichloromethyl, fluoromethyl , Difluoromethyl, trifluoromethyl, chlorofluoromethyl, dichlorofluoromethyl, chlorodifluoromethyl, 1-chloroethyl, 1-bromoethyl, 1-fluoroethyl, 2-fluoroethyl, 2,2-difluoroethyl, 2,2,2-trifluoroethyl, 2-chloro-2-fluoroethyl , 2-chloro-2,2-difluoroethyl, 2,2-dichloro-2-fluoroethyl, 2,2,2-trichloroethyl
• Aikenyl unsaturated, straight-chain or branched hydrocarbon radicals having 2 to 4 or 8 carbon atoms and a double bond in any position, for example C 2 -C 6 -alkenyl, such as ethenyl, 1-propenyl, 2-propenyl, 1-methylethenyl, 1-butenyl, 2-butenyl, 3-butenyl, 1-methyl-1-propenyl, 2-methyl-1-propenyl, 1-methyl-2-propenyl, 2-methyl-2-propenyl, 1-pentenyl, 2-pentenyl, 3 Pentenyl, 4-pentenyl, 1-methyl-1-butenyl, 2-methyl-1-butenyl, 3-methyl-1-butenyl, 1-methyl-2-butenyl, 2-methyl-2-butenyl, 3-methyl 2-butenyl, 1-methyl-3-butenyl, 2-methyl-3-butenyl, 3-methyl-3-butenyl, 1,1-dimethyl-2-propenyl,
• Haloalkenyl unsaturated, straight-chain or branched hydrocarbon radicals having 2 to 6 carbon atoms and a double bond in any position (as mentioned above), wherein in these groups the hydrogen atoms are partially or completely replaced by halogen atoms as mentioned above, in particular fluorine, chlorine and bromine can;
• Alkynyl straight-chain or branched hydrocarbon groups having 2 to 8 carbon atoms and a triple bond in any position, for example C 2 -C 6 -alkynyl, such as ethynyl, 1-propynyl, 2-propynyl, 1-butynyl, 2-butynyl, 3-butynyl, 1-methyl-2-propynyl, 1-pentynyl, 2-pentynyl, 3-pentynyl, 4-pentynyl, 1-methyl-2-butynyl, 1-methyl-3-butynyl, 2-methyl-3-butynyl, 3 Methyl-1-butynyl, 1,1-dimethyl-2-propynyl, 1-ethyl-2-propynyl, 1-hexynyl, 2-hexynyl, 3-hexynyl, 4-hexynyl, 5-hexynyl, 1-methyl-2- pentyny
• Cycloalkyl mono- or bicyclic, saturated hydrocarbon groups having 3 to 6 carbon ring members, for example C 3 -C 6 -cycloalkyl, such as cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl;
• 5-membered heteroaryl containing one to four nitrogen atoms or one to three nitrogen atoms and one sulfur or oxygen atom 5-membered heteroaryl groups, which besides carbon atoms may contain one to four nitrogen atoms or one to three nitrogen atoms and one sulfur or oxygen atom as ring members , eg 2-furyl, 3-furyl, 2-thienyl, 3-thienyl, 2-pyrrolyl, 3-pyrrolyl, 3-isoxazolyl, 4-isoxazolyl, 5-isoxazolyl, 3-isothiazolyl, 4-isothiazolyl, 5-isothiazolyl, 3 Pyrazolyl, 4-pyrazolyl, 5-pyrazolyl, 2-oxazolyl, 4-oxazolyl, 5-oxazolyl, 2-thiazolyl, 4-thiazolyl, 5-thiazolyl, 2-imidazolyl, 4-imidazolyl, 1, 2,4-oxadiazole 3-yl, 1, 2,4-oxadia
• 6-membered heteroaryl containing one to three or one to four nitrogen atoms 6-membered ring heteroaryl groups, which in addition to carbon atoms may contain one to three or one to four nitrogen atoms as ring members, e.g. 2-pyridinyl, 3-pyridinyl, 4-pyridinyl, 3-pyridazinyl, 4-pyridazinyl, 2-pyrimidinyl, 4-pyrimidinyl, 5-pyrimidinyl, 2-pyrazinyl, 1, 3,5-triazin-2-yl and 1, 2,4-triazine-3-yl;
• Compounds I are additionally preferred in which R 1 CC 6 alkyl, CC 6 -HalogenaIkyl, C 2 - are Ce-alkenyl, C 2 -C 6 -AIkinyl or C 3 -C 6 cycloalkyl and R 2 is hydrogen.
• R 1 is branched in ⁇ -position CrCe-alkyl, C 2 -C 6 -alkenyl or CC 6 -haloalkyl.
• R 1 is CC-haloalkyl and R 2 is hydrogen.
• R 1 and R 2 together with the nitrogen to which they are attached form a five- or six-membered ring which may be interrupted by an oxygen atom and may carry one or two dC 6 -alkyl substituents.
• NR.sup.R 2 such as-in particular in the ⁇ -position-methylated pyrrolidines or piperidines.
• 4-methylpiperidine is preferred.
• pyrimidines I are particularly preferred, where the subscript n and the substituents L 1 to L 5 have the following meaning:
• pyrimidines I are preferred, the substituents L 1 to L 5 having the following meanings:
• R u is halogen, cyano, d-ds-alkyl, C 2 -C 6 -alkenyl, C 2 -C 6 -alkynyl, dC 6 -alkoxy, C 2 -C 6 -alkenyloxy, C 2 -C 6 alkynyloxy.
• L 1 is fluorine, chlorine, CH 3 or CF 3 ;
• L 2 , L 4 are independently hydrogen, CH 3 or fluorine;
• L 5 is hydrogen, fluorine, chlorine or CH 3.
• R 3 denotes C 1 -C 4 -alkyl which may be substituted by halogen.
• compounds I are particularly preferred in which R 3 is halogen, cyano, C 1 -C 4 -alkyl or C 1 -C 4 -alkoxy.
• R 3 is methyl, cyano, methoxy or especially chlorine.
• R 4 may preferably have the following meanings, which may also be understood as prodrug residue definitions (see Medicininal Research Reviews 2003, 23, 763-793, or J. of Pharmaceutical Sciences 1997, 86, 765-767):
• n in the alkenylene radicals of the above formulas stands for an integer from 1 to 3.
• the substituent R a is preferably hydrogen, methyl, allyl or propargyl and particularly preferably hydrogen.
• the substituent R b preferably denotes hydrogen, CC 6 -alkyl or C 2 -C 6 -alkenyl and particularly preferably: methyl, allyl or propargyl.
• the substituent R c is preferably hydrogen or methyl.
• Table 54 Compounds of the formulas Ia, Ib, Ic, Id, Ie and If in which L n is 2,4,5-trifluoro, R 3 is chlorine and R 1 , R 2 for each compound corresponds to one row of Table A.
• Table 62 Compounds of the formulas Ia, Ib, Ic, Id, Ie and If in which L n is 2,5-difluoro, R 3 is chlorine and R 1, R 2 for each compound corresponds to one row of Table A.
• Table 81 Compounds of the formulas Ia, Ib, Ic, Id, Ie and If in which L n is 2-methyl, 4-cyano, R 3 is chlorine and R 1 , R 2 for each compound corresponds to one row of Table A.
• Table 90 Compounds of the formulas Ia, Ib, Ic, Id, Ie and If in which L n is pentafluoro, R 3 is chlorine and R 1 , R 2 for each compound corresponds to one row of Table A.
• Table 107 Compounds of the formulas Ia, Ib, Ic, Id, Ie and If in which L n is 2,5-difluoro, R 3 is methoxy and R 1 , R 2 for each compound corresponds to one row of Table A.
• Methoxy and R 1 , R 2 for a compound corresponds in each case to one row of Table A.
• Table 140 Compounds of the formulas Ia, Ib, Ic, Id, Ie and If, in which L n is 2,4,6-trifluoro, R 3 is cyano and R, R 2 for each compound corresponds to one row of Table A.
• Table 149 Compounds of the formulas Ia, Ib, Ic, Id, Ie and If in which L n is 2-fluoro-4-chloro, R 3 is cyano and R 1 , R 2 for each compound corresponds to one row of Table A.
• Table 154 Compounds of the formulas Ia, Ib, Ic, Id, Ie and If in which L n is 2-methyl, R 3 is cyano and R 1 , R 2 for each compound corresponds to one row of Table A.
• Table 159 Compounds of the formulas Ia, Ib, Ic, Id, Ie and If, in which L n is 2,4,6-trimethyl, R 3 is cyano and R 1 , R 2 for each compound corresponds to one row of Table A.
• Table 170 Compounds of the formulas Ia, Ib, Ic, Id, Ie and If in which L n is 2,5-dimethyl, R 3 is cyano and R 1 , R 2 for each compound corresponds to one row of Table A.
• the compounds I are suitable as fungicides. They are distinguished by outstanding activity against a broad spectrum of phytopathogenic fungi, in particular from the classes of the Ascomycetes, Deuteromycetes, Oomycetes and Bassidiomycetes. They are in part systemically effective and can be used in crop protection as foliar and soil fungicides.
• the compounds I are also suitable for controlling harmful fungi such as Pecilomyces variotii in the protection of materials (for example wood, paper, paint dispersions, fibers or fabrics) and in the protection of stored products.
• harmful fungi such as Pecilomyces variotii in the protection of materials (for example wood, paper, paint dispersions, fibers or fabrics) and in the protection of stored products.
• the compounds I are used by treating the fungi or the plants, seeds, materials or the soil to be protected against fungal attack with a fungicidally effective amount of the active ingredients.
• the application can be done both before and after the infection of the materials, plants or seeds by the fungi.
• the fungicidal compositions generally contain between 0.1 and 95, preferably between 0.5 and 90 wt .-% of active ingredient.
• the application rates in the application in crop protection depending on the nature of the desired effect between 0.01 and 2.0 kg of active ingredient per ha.
• active ingredient in general, amounts of active ingredient of 0.001 to 0.1 g, preferably 0.01 to 0.05 g per kilogram of seed are needed.
• application rate of active ingredient depends on the type of application and the desired effect.
• Usual up 'are wall quantities kg in the protection of materials for example, 0.001 g to 2, preferably 0.005 g to 1 kg of active ingredient per cubic meter of treated material.
• the compounds I can be converted into the usual formulations, e.g. Solutions, emulsions, suspensions, dusts, powders, pastes and granules.
• the application form depends on the respective purpose; In any case, it should ensure a fine and uniform distribution of the compound according to the invention.
• the formulations are prepared in a known manner, e.g. by stretching the active ingredient with solvents and / or carriers, if desired using emulsifiers and dispersants.
• Suitable solvents / auxiliaries are essentially:
• aromatic solvents eg Solvesso products, xylene
• paraffins eg petroleum fractions
• alcohols eg methanol, butanol, pentanol, benzyl alcohol
• ketones eg cyclohexanone, gamma-butyrolactone
• pyrrolidones NMP, NOP
• Acetates glycols, dimethyl fatty acid amides, fatty acids and fatty acid esters.
• solvent mixtures can also be used
• Excipients such as ground natural minerals (e.g., kaolins, clays, talc, chalk) and ground synthetic minerals (e.g., fumed silica, silicates); Emulsifiers such as nonionic and anionic emulsifiers (for example polyoxyethylene fatty alcohol ethers, alkyl sulfonates and aryl sulfonates) and dispersants such as lignin-sulphite liquors and methylcellulose.
• ground natural minerals e.g., kaolins, clays, talc, chalk
• ground synthetic minerals e.g., fumed silica, silicates
• Emulsifiers such as nonionic and anionic emulsifiers (for example polyoxyethylene fatty alcohol ethers, alkyl sulfonates and aryl sulfonates) and dispersants such as lignin-sulphite liquors and methylcellulose.
• the surface-active substances used are alkali metal, alkaline earth metal, ammonium salts of lignin sulfonic acid, naphthalenesulfonic acid, phenolsulfonic acid, dibutylnaphthalenesulfonic acid, alkylarylsulfonates, alkyl sulfates, alkyl sulfonates, fatty alcohol sulfates, fatty acids and sulfated fatty alcohol glycol ethers, and condensation products of sulfonated naphthalene and naphthaine derivatives with formaldehyde , Condensation products of naphthalene or naphthalenesulfonic acid with phenol and formaldehyde, polyoxyethylene octylphenol ether, ethoxylated isooctylphenol, octylphenol, nonylphenol, alkylphenol polyglycol ethers, tributylphenyl polyg
• mineral oil fractions of medium to high boiling point such as kerosene or diesel oil, coal tar oils and oils of vegetable or animal origin, aliphatic, cyclic and aromatic hydrocarbons, eg toluene, Xylene, paraffin, tetrahydronaphthalene, alkylated naphthalenes or their derivatives, methanol, ethanol, propanol, butanol, cyclohexanol, cyclohexanone, isophorone, strongly polar solvents, for example dimethylsulfoxide, N-methylpyrrolidone or water into consideration.
• mineral oil fractions of medium to high boiling point such as kerosene or diesel oil, coal tar oils and oils of vegetable or animal origin
• aliphatic, cyclic and aromatic hydrocarbons eg toluene, Xylene, paraffin, tetrahydronaphthalene, alkylated naphthalenes or their derivatives, methanol
• Powders, dispersants and dusts may be prepared by mixing or co-grinding the active substances with a solid carrier.
• Granules e.g. Coated, impregnated and homogeneous granules can be prepared by binding the active compounds to solid carriers.
• Solid carriers are e.g. Mineral earths, such as silica gels, silicates, talc, kaolin, attaclay, limestone, lime, chalk, bolus, loess, clay, dolomite, diatomaceous earth, calcium and magnesium sulphate, magnesium oxide, ground plastics, fertilizers, e.g. Ammonium sulfate, ammonium phosphate, ammonium nitrate, ureas and vegetable products such as cereal flour, bark, wood and nutshell flour, cellulose powder and other solid carriers.
• Mineral earths such as silica gels, silicates, talc, kaolin, attaclay, limestone, lime, chalk, bolus, loess, clay, dolomite, diatomaceous earth, calcium and magnesium sulphate, magnesium oxide, ground plastics,
• the formulations generally contain between 0.01 and 95 wt .-%, preferably between 0.1 and 90 wt .-% of the active ingredient.
• the active ingredients are used in a purity of 90% to 100%, preferably 95% to 100% (according to NMR spectrum).
• formulations are: 1. Products for dilution in water
• a compound of the invention 10 parts by weight of a compound of the invention are dissolved in water or a water-soluble solvent. Alternatively, wetting agents or other adjuvants are added. When diluted in water, the active ingredient dissolves.
• Emulsions EW, EO 40 parts by weight of a compound according to the invention are dissolved in xylene with addition of calcium dodecylbenzenesulfonate and castor oil ethoxylate O 'in each case 5%). This mixture is introduced by means of an emulsifier (Ultraturax) in water and brought to a homogeneous emulsion. Dilution in water results in an emulsion.
• an emulsifier Ultraturax
• a compound of the invention 20 parts by weight of a compound of the invention are comminuted with the addition of dispersants and wetting agents and water or an organic solvent in a stirred ball mill to a fine suspension of active substance. Dilution in water results in a stable suspension of the active ingredient.
• a compound according to the invention 50 parts by weight of a compound according to the invention are finely ground with the addition of dispersants and wetting agents and prepared by means of industrial equipment (for example extrusion, spray tower, fluidized bed) as water-dispersible or water-soluble granules. Dilution in water results in a stable dispersion or solution of the active ingredient.
• industrial equipment for example extrusion, spray tower, fluidized bed
• 75 parts by weight of a compound according to the invention are ground with the addition of dispersants and Netzmittein and silica gel in a rotor-Strator mill. Dilution in water results in a stable dispersion or solution of the active ingredient.
• Granules (GR, FG, GG, MG) 0.5 parts by weight of a compound according to the invention are finely ground and combined with 95.5% excipients. Common processes are extrusion, spray drying or fluidized bed. This gives granules for direct application.
• the active compounds may be used as such, in the form of their formulations or the forms of use prepared therefrom, e.g. be applied in the form of directly sprayable solutions, powders, suspensions or dispersions, emulsions, Oldispersionen, pastes, dusts, scattering agents, granules by spraying, atomizing, dusting, scattering or pouring.
• the forms of application depend entirely on the intended use; In any case, they should ensure the finest possible distribution of the active compounds according to the invention.
• Aqueous application forms can be prepared from emulsion concentrates, pastes or wettable powders (spray powder, old dispersions) by adding water.
• the substances as such or dissolved in an oil or solvent, can be homogenized in water by means of wetter, tackifier, dispersant or emulsifier.
• the active compound concentrations in the ready-to-use preparations can be varied within wide ranges. In general, they are between 0.0001 and 10%, preferably between 0.01 and 1%.
• the active ingredients can also be used with great success in the ultra-low-volume (ULV) process, it being possible to apply formulations containing more than 95% by weight of active ingredient or even the active ingredient without additives.
• UUV ultra-low-volume
• wetting agents To the active ingredients oils of various types, wetting agents, adjuvants, herbicides, fungicides, other pesticides, bactericides, optionally also just before use (tank mix), are added. These agents can be added to the inventive compositions in a weight ratio of 1:10 to 10: 1.
• the agents according to the invention in the form of application as fungicides, may also be present together with other active substances, e.g. with herbicides, insecticides, growth regulators, fungicides or with fertilizers.
• other active substances e.g. with herbicides, insecticides, growth regulators, fungicides or with fertilizers.
• Acylalanines such as benalaxyl, metalaxyl, ofurace, oxadixyl,
• Amine derivatives such as aldimorph, dodine, dodemorph, fenpropimorph, fenpropidin, guazatine, iminoctadine, spiroxamine, tridemorph
• Anilinopyrimidines such as pyrimethanil, mepanipyrim or cyrodinyl,
• Antibiotics such as cycloheximide, griseofulvin, kasugamycin, natamycin, polyoxin or streptomycin,
• Azoles such as bitertanol, bromoconazole, cyproconazole, difenoconazole, dinitroconazole, epoxiconazole, fenbuconazole, fluquiconazole, flusilazole, flutriafol, hexaconazole, imazalil, metconazole, myclobutanil, penconazole, propiconazole, prochlorazole, prothioconazole, tebuconazole, triadimefon, triadimol, triflumizole , Triticonazole,
• Dicarboximides such as iprodione, myclozoline, procymidone, vinclozolin, Dithiocarbamates such as Ferbam, Nabam, Maneb, Mancozeb, Metam, Metiram, Propenb, Polycarbamate, Thiram, Ziram, Zineb,
• Heterocyclic compounds such as anilazine, benomyl, boscalid, carbendazim, carboxin, oxycarboxin, cyazofamide, dazomet, dithianone, famoxadone, fenamidone, fenarimol, fuberidazole, flutolanil, furametpyr, isoprothiolane, mepronil, radinol, probenazole, proquinazide, pyrifenox, Pyroquilon, quinoxyfen, silthiofam, thiabendazole, thifluzamide, thiophanate-methyl, tiadinil, tricyclazole, triforine,
• Copper fungicides such as Bordeaux broth, copper acetate, copper oxychloride, basic copper sulfate,
• Nitrophenyl derivatives such as binapacryl, dinocap, dinobutone, nitrophthalic-isopropyl
• Phenylpyrroles such as fenpiclonil or fludioxonil
• Fungicides such as Acibenzolar-S-methyl, Benthiavalicarb, Carpropamid, Chlorothalonil, Cyflufenamid, Cymoxanil, Dazomet, Diclomezine, Diclocymet, Diethofencarb, Edifenphos, Ethaboxam, Fenhexamid, Fentin-acetate, Fenoxanil, Ferimzone, Fluazinam, Fosetyl, Fosetyl-Aluminum, Iprovalicarb, hexachlorobenzene, metrafenone, pencycuron, propamocarb, phthalide, tolclofos-methyl, quintozene, zoxamide
• Strobilurins such as azoxystrobin, dimoxystrobin, fluoxastrobin, kresoxim-methyl, metominostrobin, orysastrobin, picoxystrobin, pyraclostrobin or trifloxystrobin,
• Sulphonic acid derivatives such as captafol, captan, dichlofluanid, folpet, tolylfluanid
• Cinnamic acid amides and analogues such as dimethomorph, flumetover or flumorph.
• the active compounds were prepared separately as a stock solution formulated with 0.25% by weight of active compound in acetone or DMSO. To this solution was added 1% by weight of emulsifier Uniperol® EL (wetting agent with emulsifying and dispersing action based on ethoxylated alkylphenols). The stock solutions of the active ingredients were diluted with water according to the concentration indicated.
• emulsifier Uniperol® EL wetting agent with emulsifying and dispersing action based on ethoxylated alkylphenols.
• Paprika seedlings of the cultivar "Neusiedler Ideal Elite" were sprayed to drip point after 4 - 5 leaves had developed well, with an aqueous suspension in an active ingredient concentration of 250 ppm.
• the treated plants were inoculated with a spore suspension of Botrytis cinerea containing 1.7 x 10 6 spores / ml in a 2% aqueous biomalt solution.
• the test plants were placed in a climatic chamber with 22 to 24 ° C and high humidity. After 5 days, the extent of fungal attack on the leaves could be determined visually in%.
• Leaves of pot-grown cucumber seedlings of the "Chinese snake” variety were sprayed to drip point in the cotyledon stage with an aqueous suspension in an active ingredient concentration of 250 ppm. 20 hours after the spray coating dried on, the plants were inoculated with an aqueous spore suspension of cucumber powdery mildew (Sphaerotheca fuliginea). Subsequently, the plants were cultivated in the greenhouse at temperatures between 20 and 24 ° C and 60 to 80% relative humidity for 7 days. Then, the extent of mildew development was determined visually in% of the cotyledon area. In this experiment, the plants treated with compounds 1-2, 1-3, 1-4, 1-5, 1-6, 1-7, 1-8, 1-9, 1-10 and 1-11 showed no or an infestation below 10% while the untreated plants were 100% infected.
• Leaves of golden prickly potted plants were sprayed to drip point with an aqueous suspension at a drug concentration of 250 ppm The following day, the leaves were seeded with an aqueous spore suspension of Alternaria solani in 2% biomalt solution with a density of 0.17 ⁇ 10 6 The plants were then placed in a water vapor-saturated chamber at temperatures between 20 and 22 ° C. After 5 days, the disease on the untreated but infected control plants developed so strongly that the infestation could be determined visually in% ,

Landscapes

• Chemical & Material Sciences (AREA)
• Organic Chemistry (AREA)
• Plural Heterocyclic Compounds (AREA)
• Agricultural Chemicals And Associated Chemicals (AREA)
• Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
• Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Applications Claiming Priority (2)

Publications (1)

Family

ID=34201382

Family Applications (1)

Country Status (22)

Families Citing this family (4)

Family Cites Families (2)

• 2004
  • 2004-07-03 CA CA002532568A patent/CA2532568A1/en not_active Abandoned
  • 2004-07-03 WO PCT/EP2004/007258 patent/WO2005019187A1/de active Application Filing
  • 2004-07-03 EA EA200600171A patent/EA200600171A1/ru unknown
  • 2004-07-03 AU AU2004266783A patent/AU2004266783A1/en not_active Abandoned
  • 2004-07-03 KR KR1020067001494A patent/KR20060052858A/ko not_active Application Discontinuation
  • 2004-07-03 JP JP2006520707A patent/JP2006528600A/ja active Pending
  • 2004-07-03 BR BRPI0412783-8A patent/BRPI0412783A/pt not_active IP Right Cessation
  • 2004-07-03 US US10/565,656 patent/US7317015B2/en not_active Expired - Fee Related
  • 2004-07-03 MX MXPA06000383A patent/MXPA06000383A/es unknown
  • 2004-07-03 EP EP04740605A patent/EP1651617A1/de not_active Withdrawn
  • 2004-07-03 CN CNA2004800213534A patent/CN1826327A/zh active Pending
  • 2004-07-03 AP AP2006003496A patent/AP2006003496A0/xx unknown
  • 2004-07-08 PE PE2004000655A patent/PE20050248A1/es not_active Application Discontinuation
  • 2004-07-15 TW TW093121181A patent/TW200524881A/zh unknown
  • 2004-07-15 CN CNB200480021440XA patent/CN100425595C/zh not_active Expired - Fee Related
  • 2004-07-23 AR ARP040102630A patent/AR045099A1/es unknown
  • 2004-07-23 UY UY28437A patent/UY28437A1/es unknown
• 2005
  • 2005-12-27 IL IL172845A patent/IL172845A0/en unknown
• 2006
  • 2006-01-11 CR CR8185A patent/CR8185A/es not_active Application Discontinuation
  • 2006-01-19 EC EC2006006295A patent/ECSP066295A/es unknown
  • 2006-01-24 CO CO06006390A patent/CO5660291A2/es not_active Application Discontinuation
  • 2006-02-14 MA MA28802A patent/MA27947A1/fr unknown
  • 2006-02-22 ZA ZA200601541A patent/ZA200601541B/en unknown
  • 2006-02-22 ZA ZA200601540A patent/ZA200601540B/en unknown

Non-Patent Citations (1)

Also Published As

Similar Documents

Legal Events